News
anti-VEGF
Anti-VEGF injections may be linked to increased risk of cataracts
Several eye conditions are treated using anti-VEGF injections including retinal vein occlusion, diabetic macular edema and wet age-related macular degeneration.
diabetic macular edema
Eydenzelt receives FDA approval for four retinal diseases
Eydenzelt is approved for use in treating wet age-related macular degeneration, macular edema following reetinal vein occlusion, diabetic macular edema and diabetic retinopathy.
blindness
Retinal vein occlusion may be helped by new eye drops
Retinal vein occlusion is a major cause of blindness that is caused by a blockage in the major vein that drains blood from the retina.